Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Colorectal Neoplasms

Free Subscription Articles published in Clin Res Hepatol Gastroenterol Retrieve available abstracts of 13 articles: HTML format

Single Articles

May 2025
1. ZHAO J, Miao D
   Precision Oncology in Colorectal Cancer: An Anatomical Revolution Through Molecular-Clinical Integration Across Colonic Subsites.
   Clin Res Hepatol Gastroenterol. 2025 May 13:102613.
   PubMed     Abstract available
   
   
   
2. VO-QUANG E, Gandini A, Taly V, Puig PL, et al
   Circulating tumor DNA: a new tool to predict recurrence and guide treatment of colorectal cancer.
   Clin Res Hepatol Gastroenterol. 2025 May 7:102611.
   PubMed     Abstract available
   
   
   March 2025
3. LI Y, Ma XM, Jia JG, Cao LY, et al
   Association between metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction subtypes and risk of colorectal cancer: A Prospective Cohort Study.
   Clin Res Hepatol Gastroenterol. 2025 Mar 15:102573.
   PubMed     Abstract available
   
   
   January 2025
4. DABOUT V, Mineur L, Tougeron D, Malicot KL, et al
   Induction triplet chemotherapy in patients with rectal adenocarcinoma and synchronous metastases, an AGEO-FFCD study.
   Clin Res Hepatol Gastroenterol. 2025;49:102514.
   PubMed     Abstract available
   
   
   November 2024
5. WANG J, Zhang X, Chen K, Liang Y, et al
   Optimization of endoscopic treatment strategies for R0 resection of rectal neuroendocrine tumors smaller than 10 mm.
   Clin Res Hepatol Gastroenterol. 2024;48:102469.
   PubMed     Abstract available
   
   
   October 2024
6. GOMEZ CIFUENTES JD, Berger S, Thrift AP, Ketwaroo G, et al
   Baylor College of Medicine (BCM) model predicts recurrence after mucosectomy of colorectal lateral spreading tumors in European cohorts.
   Clin Res Hepatol Gastroenterol. 2024;48:102460.
   PubMed    
   
   
   September 2024
7. JIN KM, Bao Q, Zhao TT, Wang HW, et al
   Comparing Baseline VAF in Circulating tumor DNA and Tumor Tissues Predicting Prognosis of Patients with Colorectal Cancer Liver Metastases After Curative Resection.
   Clin Res Hepatol Gastroenterol. 2024 Sep 12:102464.
   PubMed     Abstract available
   
   
   August 2024
8. BRAGANCA S, Garcia AC, Alexandrino G, Oliveira AM, et al
   Validation of a novel BCM model for recurrence risk prediction after mucosectomy of colorectal lateral spreading tumors in a European cohort.
   Clin Res Hepatol Gastroenterol. 2024;48:102414.
   PubMed     Abstract available
   
   
   July 2024
9. AL-HAIDERI M
   Silymarin Suppresses Proliferation and PD-L1 expression in Colorectal Cancer Cells and Increases Inflammatory CD8+ Cells in Tumor-Bearing Mice.
   Clin Res Hepatol Gastroenterol. 2024 Jul 22:102425.
   PubMed     Abstract available
   
   
   
10. KOURIE HR, Zouein J, Zalaquett Z, Chebly A, et al
    Liquid biopsy as a tool for KRAS/NRAS/BRAF baseline testing in metastatic colorectal cancer.
    Clin Res Hepatol Gastroenterol. 2024 Jul 13:102417.
    PubMed     Abstract available
    
    
    May 2024
11. CAZENEUVE N, Bouche O, Leger J, Borg C, et al
    Visceral fat and clinical outcome in patients receiving first-line chemotherapy with bevacizumab for metastatic colorectal cancer.
    Clin Res Hepatol Gastroenterol. 2024 May 22:102380.
    PubMed     Abstract available
    
    
    
12. LU H, Wang H, Zhu L, Xu J, et al
    The impact of WeChat online education and care on the mental distress of caregivers and satisfaction of elderly postoperative colorectal cancer patients.
    Clin Res Hepatol Gastroenterol. 2024 May 6:102372.
    PubMed     Abstract available
    
    
    March 2024
13. RAN D, Xin C, Ma Y, Lu Y, et al
    Increased risk of colorectal adenomas with metabolic-associated fatty liver disease components.
    Clin Res Hepatol Gastroenterol. 2024;48:102302.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.